1 This
remained 100-fold lower than baseline during the 3 year-
2 with a few molecules in artificial cells has
remained a challenge.
3 xchange on chip for large numbers of embryos
remains a bottleneck.
4 ions in COVID-19, lung transplantation (LTx)
remains a critical life-saving operation.
5 gens, acquired resistance to hormone therapy
remains a major challenge in treating advanced prostate
6 ate-to-high doses of opioids and expected to
remain alive and ventilated for an additional 48 hours a
7 However, matter-wave interferometry has
remained an outstanding challenge for natural polypeptid
8 and produces two-fragment holoreceptors that
remain bound at the cell surface.
9 s and within dynamic molecular regimes often
remain difficult to ascertain.
10 ation dynamics during inflammatory responses
remain enigmatic.
11 ation, and filament growth in cable bacteria
remains enigmatic.
12 The precise roles of the five
remaining genes (Flcn, Map1lc3b, Me2, Prkd2, and Scarb2)
13 deleted in gut using Villin-Cre, female mice
remain healthy despite significant X-autosome dosage imb
14 matchmaking RNA chaperone, significant gaps
remain in our understanding of the molecular mechanisms
15 cell (dSPB) during anaphase and the SPB that
remains in the mother cell.
16 lignant transformation at the junction areas
remain insufficiently elucidated.
17 ci selected for improving grain productivity
remain largely unclear.
18 ing enzymatic activities, the rates of which
remain largely unknown.
19 or rise to detectable frequencies by chance
remains largely unknown.
20 However, patient access
remains limited because of restricted insurance coverage
21 ad 3-times higher risk compared to those who
remained negative (21.8% vs 8.5%, p=0.01; OR 3.0, 95%CI
22 erpin mutational selection in normal tissues
remain poorly understood.
23 type, the associated capsular polysaccharide
remains poorly characterized.
24 egulatory elements, yet how this is achieved
remains poorly understood.
25 demic's overall effect on the RRT population
remained remarkably limited in Flanders.
26 The resulting burns
remain sensitive to touch for weeks, but it is unknown w
27 There
remain significant regional disparities in the managemen
28 om clinical trials of various AKT inhibitors
remain suboptimal, suggesting that AKT-driven tumor meta
29 nes (Flcn, Map1lc3b, Me2, Prkd2, and Scarb2)
remain to be determined.
30 l survival and apoptosis signaling in cancer
remain to be elucidated.
31 Though its therapeutic mechanisms
remain unclear, it has been suggested that antidromic ac
32 -sensing mechanisms and disease consequences
remain unclear.
33 riable severity of peanut-allergic reactions
remain unclear.
34 gands in such intriguing additional capacity
remain unclear.
35 intensively studied in colorectal cancer, it
remains unclear whether activity in the tumor-associated
36 zation vary with bioenergy crop species also
remains unclear.
37 cise role of GR in the pathophysiology of AD
remains unclear.
38 mong these patients in contemporary practice
remains unclear.
39 ter DAA therapy can improve hepatic fibrosis
remains unclear.
40 ease or merely represents a bystander effect
remains unclear.
41 gulated to ensure efficient spindle assembly
remains unclear.
42 accelerate catalyst development which still
remains underexplored.
43 HCC surveillance
remains underused in clinical practice, particularly amo
44 lved in the activation of many viral strains
remain unidentified.
45 s outgroup deficit in observational learning
remained unknown, which limits our chances to improve in
46 wever, the molecular basis for these effects
remains unknown.
47 s controlled via trans-synaptic interactions
remains unknown.
48 fleet has been widely documented, its extent
remains unknown.
49 the main opiate receptor of skin mast cells
remains unknown.
50 owever, predicting a conserved RNA structure
remains unreliable, even when using a combination of the